CNO Stock Analysis: Buy, Sell, or Hold?
CNO - CNO Financial Group, Inc.
$53.52
0.41 (0.77%)
â˛
5d:
-3.18%
30d:
+1.75%
90d:
+12.96%
WAIT
LOW Confidence
Analysis Updated: Aug 21, 2026 12:00 AM ET
Earnings: Jul 30, 2026
0d
Get Alerted When CNO Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
âšī¸ NEUTRAL: CNO is fairly priced but lacks strong directional signals. At 3.6% expected growth, valuation appears fair. Wait for clearer setup or better entry on dips.
âšī¸ NEUTRAL: CNO is fairly priced but lacks strong directional signals. At 3.6% expected growth, valuation appears fair. Wait for clearer setup or better entry on dips.
Long-Term Wealth Forecast (2031)
Based on Analyst Consensus Growth & Historical Valuation
0% (Stagnation)
50% (Hyper Growth)
EST. PRICE IN 2031
$64.11
Based on 5.9% avg growth
INTRINSIC VALUE TODAY
$39.81
Trading above historical range
How this is calculated: We use a Growth Decay Model: starting with analyst consensus growth (adjusted above) and gradually slowing it down to a long-term terminal rate (4%) by Year 5. This provides a more realistic valuation than assuming constant hyper-growth. We then apply a 9.6x Exit PE.
In-depth Analysis How we analyze
Valuation Analysis: CNO is currently trading at $53.52, which is considered slightly low relative to its 30-day fair value range of $53.06 to $55.05. From a valuation perspective, the stock is trading at a premium (Forward PE: 10.6) compared to its historical average (9.6). At these levels, the market is pricing in 3.6% annual earnings growth. This growth rate appears achievable given the company's track record, suggesting the valuation is rational.
Technical Outlook: Technically, CNO is in a strong uptrend. The price is currently testing key support at $52.83. A bounce from this level would confirm strength, while a break below could signal further downside.
Market Sentiment: CNO scores 33/100 on our bottoming-setup gauge. Note this measures entry quality, not trend direction — a low score can mean the chart is extended after a strong run (don't chase) or still falling without stabilization; better entries typically come after a pullback toward the 20-day average. Current signals suggest waiting for a better entry point before initiating new positions.
Technical Outlook: Technically, CNO is in a strong uptrend. The price is currently testing key support at $52.83. A bounce from this level would confirm strength, while a break below could signal further downside.
Market Sentiment: CNO scores 33/100 on our bottoming-setup gauge. Note this measures entry quality, not trend direction — a low score can mean the chart is extended after a strong run (don't chase) or still falling without stabilization; better entries typically come after a pullback toward the 20-day average. Current signals suggest waiting for a better entry point before initiating new positions.
Quick Decision Summary
Current Position
SLIGHTLY LOW
Historical Trading Range
$53.06 -
$55.05
Company Quality Score
33/100
(SELL)
Volume Confirmation
HIGH
Confidence Score
53.3%
All Signals
- BULLISH: Price oversold vs 30-day range
- BEARISH: Weak technical setup (33/100)
- BULLISH: High volume confirmation
- NEUTRAL: Near Wall St target ($53.75)
- NEUTRAL: Market pricing in 3.6% annual earnings growth - fairly valued
- WARNING: Composite score 32/100 in the bottom quintile â this cohort historically lags the market
Trading Range Analysis
30-Day Trading Range
$53.06 -
$55.05
Current vs Trading Range
SLIGHTLY LOW
Support & Resistance Levels
Support Level
$52.83
Resistance Level
$55.85
Current Trend
Strong Uptrend
Technical data as of
Aug 21, 2026
Fundamental Context
Forward P/E (Next Year Est.)
10.64
Wall Street Target
$53.75
(+0.4%)
Revenue Growth (YoY)
11.6%
Earnings Growth (YoY)
46.2%
Profit Margin
6.0%
Valuation Premium vs History
+3.6% premium
PE vs Historical
10.6 vs 9.6
FAIR
Market-Implied Price Targets
If current PE multiple persists
Implied Growth (YoY):
+3.6%
(market-implied from PE analysis)
1-Year Target
$55.45
(+4%)
2-Year Target
$57.44
(+7%)
3-Year Target
$59.51
(+11%)
3-Yr Target (if PE normalizes)
(PE: 11â10)
PE COMPRESSION
$53.67
(+0%)
Earnings growth offset by PE compression
3-Year Scenarios
Using analyst projected EPS growth
Bull:
(PE: 20.1, Growth: 7.7%)
$125.94
(+135%)
Base:
(SPY PE: 10.6, Growth: 7.7%)
$66.80
(+25%)
Bear:
(PE: 9.0, Growth: 7.7%)
$56.78
(+6%)
đ
Valuation based on Current Earnings
RECOVERY PLAY: Stock looks expensive now (18x PE), but valuation improves significantly next year (11x PE) as earnings recover.
Trailing PE: 18.38 | Current EPS (TTM): $2.89
Bull Case
$101.64
(+90%)
Analyst growth 74.0%, PE expands to 20.2
Base Case
$92.40
(+73%)
Market implied 74.0%, PE stable at 18.4
Bear Case
$36.11
(-33%)
Severe decline -20.0%, PE contracts to 15.6
These are projections based on PE multiples and EPS growth scenarios, not predictions. Actual results may vary significantly.
Share & Embed Analysis
Last updated: August 23, 2026 10:29 AM ET
Data refreshes hourly during market hours. Next update: 11:29 AM
Data refreshes hourly during market hours. Next update: 11:29 AM
đĨ Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is CNO showing a specific setup today?
Insider Activity (6 Months)
0
Buys
1
Sells
Net
INSIDERS SELLING
Recent Transactions
Scott L Goldberg
SELL
11060 shares
2026-03-19
Top Rated Insurance - Life Stocks
Top-rated stocks in Insurance - Life by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
MET
MetLife Inc |
STRONG BUY
16 analysts |
$104 | 36 SELL |
|
UNM
Unum Group |
BUY
13 analysts |
$101 | 53 HOLD |
|
ABL
Abacus Life Inc. |
STRONG BUY
5 analysts |
$14 | 42 HOLD |
|
MFC
Manulife Financial Corp |
BUY
13 analysts |
$35 | 33 SELL |
|
GL
Globe Life Inc |
BUY
10 analysts |
$194 | 33 SELL |
